COMPARISON OF SURGICAL OUTCOMES BETWEEN ROBOTIC GASTRECTOMY VERSUS LAPAROSCOPIC GASTRECTOMY IN GASTRIC CANCER PATIENTS ulilhabibah222@gmail.com

 

COMPARISON OF SURGICAL OUTCOMES BETWEEN ROBOTIC GASTRECTOMY VERSUS LAPAROSCOPIC GASTRECTOMY IN GASTRIC CANCER PATIENTS

2

 

 

 

 

Indonesia

Oral or Poster

Minimally invasive surgery (MIS) is critical in managing gastric cancer, with robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) as leading approaches. This study systematically compares RG and LG, focusing on morbidity rates, recovery times, inflammatory responses, lymphadenectomy quality, and overall survival to evaluate the relative benefits of each technique.

A systematic review was performed using PubMed, Cochrane Library, and EMBASE. The search included keywords such as "robotic gastrectomy," "laparoscopic gastrectomy," "gastric cancer," and "surgical outcomes." Only randomized controlled trials (RCTs) comparing RG and LG were included. Outcomes assessed were morbidity rates, operative time, blood loss, postoperative complications, recovery time, inflammatory response, lymphadenectomy quality, and overall survival.

A total of studies published between 2000 and 2024 were identified, of which 143 studies were excluded based on eligibility criteria. Three RCTs met the inclusion criteria and were included in the analysis, comprising a total of 606 patients (RGs: n = 301; LGs: n =305). RG showed significantly lower morbidity rates, faster recovery times, and better lymphadenectomy compared to LG. RG patients also had faster postoperative recovery, enabling earlier adjuvant chemotherapy. Both RG and LG had similar long-term survival outcomes and recurrence rates.

Robotic gastrectomy offers several advantages over laparoscopic gastrectomy, including reduced morbidity, quicker recovery, and improved lymphadenectomy. The faster recovery with RG may allow earlier adjuvant chemotherapy, potentially enhancing treatment benefits. Further large-scale, multicentre RCTs are needed to validate these findings and improve clinical decision-making in gastric cancer surgery.